Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Beta Bionics (BBNX) Gross Profit (2024 - 2026)

Beta Bionics' Gross Profit history spans 3 years, with the latest figure at $16.4 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 83.22% to $16.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $63.0 million, a 67.3% increase, with the full-year FY2025 number at $55.5 million, up 54.75% from a year prior.
  • Gross Profit hit $16.4 million in Q1 2026 for Beta Bionics, down from $18.9 million in the prior quarter.
  • Over the last five years, Gross Profit for BBNX hit a ceiling of $18.9 million in Q4 2025 and a floor of $7.2 million in Q1 2024.
  • Historically, Gross Profit has averaged $12.0 million across 3 years, with a median of $11.7 million in 2024.
  • Biggest five-year swings in Gross Profit: increased 24.58% in 2025 and later surged 83.22% in 2026.
  • Tracing BBNX's Gross Profit over 3 years: stood at $11.7 million in 2024, then soared by 62.07% to $18.9 million in 2025, then fell by 13.23% to $16.4 million in 2026.
  • Business Quant data shows Gross Profit for BBNX at $16.4 million in Q1 2026, $18.9 million in Q4 2025, and $15.1 million in Q3 2025.